1 results match your criteria: "aSpanish Centre for Pharmacoepidemiologic Research (CEIFE)[Affiliation]"
Incidence and risk factors for atrial fibrillation in patients with newly diagnosed heart failure.
J Cardiovasc Med (Hagerstown)
August 2016
aSpanish Centre for Pharmacoepidemiologic Research (CEIFE), Madrid, Spain bBayer Pharma AG, Epidemiology, Berlin, Germany.
Aims: We aimed to identify the incidence and risk factors for first ever atrial fibrillation among patients with newly diagnosed heart failure following initial heart failure diagnosis.
Methods: A heart failure inception cohort of patients aged 20-89 years without atrial fibrillation or cancer (N = 14 457) from 2000 to 2005 was identified from The Health Improvement Network primary care database in the United Kingdom and followed for a mean of 2.67 years.